drug screening Pharmacotyping Links Childhood Leukemia Subtypes to Treatment Response With drug sensitivity and genomic profiles on acute lymphoblastic leukemia cells, coupled with patient data, researchers saw pharmacotypes related to treatment response and outcomes. Joint Venture From SEngine, Gustave Roussy Aims to Commercialize Cancer Dx Test Across Europe Premium SEngine's PARIS test combines high-throughput drug screening of live, patient-derived tumor cells with DNA sequencing and data analysis. Broad Institute DepMap Project Could Lead to Development of New Cancer Drugs Premium At the Association for Molecular Pathology annual meeting, cancer researcher William Hahn talked about efforts to map cancer fitness genes at the genome scale. Singapore's Avatamed Raises $1M in Seed Funding Avatamed will use the funds to expand into the Asia-Pacific market and set up a lab in Singapore to provide precision cancer drug screening services. SEngine Organoid Testing Leads to Treatment Change for Two Metastatic Colorectal Cancer Patients The researchers said their new study supports the clinical utility of their test, which combines genomic and drug screening analyses of organoids to guide cancer treatment. Jul 14, 2020 Glioblastoma Brain Tumor Treatment Strategies Stem From Pharmacogenomic Analysis Jun 10, 2020 10x Genomics, MilliporeSigma Collaborate on CRISPR Screening Workflow Dec 5, 2019 High-Throughput Single-Cell Transcriptomics Assay Facilitates Compound Screens Premium Oct 2, 2019 SEngine Precision Medicine Raises $5.1M in Series A Financing Apr 10, 2019 Genome-Scale CRISPR Screening Helps Identify New Cancer Drug Targets Jan 15, 2019 Researchers Generate Catalog of Kinase Response to DNA-Damaging Agents Mar 7, 2018 French Researchers to Assess NovellusDx Assay for Ability to Predict Cancer Treatment Response Premium Oct 24, 2017 Cancer Drug Response Linked to Transcript Isoform Markers Jul 26, 2017 PLATE-Seq Method Adds Expression, Regulatory Insights to Cell Screens Premium Jul 11, 2017 SEngine Precision Medicine's Lab Garners CLIA Certification Jul 6, 2017 SEngine Precision Medicine Licenses Hutch Cancer Drug Screening Assay Dec 14, 2016 Duke Researchers Propose Combination Therapy for PIK3CA-Mutant Breast Cancer Nov 1, 2016 Agilent, PureHoney Technologies Partner to Develop New Mass Spec Applications Oct 1, 2015 Genomics Inks Drug Screening Deal With Biogen Nov 17, 2014 Horizon CombinatoRx to Profile Oncology Asset for Pharma Firm Sep 23, 2014 NIH Awards $17M for Next Phase of Tissue Chip for Drug Screening Program Jul 30, 2014 Broad Plans Large Sequencing Study to ID Personalized Drug Candidates for Psychiatric Disorders Premium Oct 8, 2013 Horizon Discovery to Support Blueprint Medicines' Cancer Research Platform Sep 11, 2013 Certara, C-Path Partner on Testing Models for Tuberculosis Drugs Sep 10, 2013 Bayer, Broad Aim to Develop Therapeutics Targeting Cancer Genome Alterations Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.